Cancer Centre London

At St George's Hospital in South London, Dr. Benepal practices as a consultant medical oncologist. After completing his residency at University College Hospital in London, he moved to Chelsea & Westminster to work as an HIV specialist. Having completed his training in oncology at the Royal Marsden, Dr. Benepal has been practicing oncology for the past 20 years, 13 of those years as a consultant at St. George's Hospital. Over his career in clinical practice, Dr. Benepal has conducted and oversaw a number of research initiatives. His primary clinical interests are lung cancer, mesothelioma, and upper gastrointestinal diseases. Dr. Benepal is the Lead for St. George's undergraduate and graduate medical students and has a strong passion for teaching. He frequently receives invitations to give lectures at conferences held abroad. View Profile

At University College London, where he pursued his medical education, Professor Angus Dalgleish earned both a BSc in anatomy and an MBBS. He is a Fellow of The Academy of Medical Scientists, The Royal College of Pathologists, and The Royal College of Physicians of the UK and Australia. He worked as a housekeeper in London and Poole after receiving his degree and then served a year in Queensland's flying doctor service. In Brisbane and Sydney, he received additional training in internal medicine and oncology. He started his MD program with Professor Robin Weiss, FRS at the Institute of Cancer Research and Royal Marsden Hospital after becoming interested in how viruses caused cancer. He spent five years working as a clinical scientist at the MRC's Northwick Park clinical research facility before being named to the Foundation Chair in Oncology at St. George's University of London in 1991. His primary research interests have been on the immunology of cancer and the creation of immunotherapies, particularly for the treatment of melanoma. He now serves on eight editorial boards, has written or co-written more than 70 chapters for medical books, and has been published in peer-reviewed scientific journals. Five medical books co-edited by him. He presently serves on the European Commission Cancer Board and has served on various funding panels. View Profile

At The Royal Marsden and The Institute of Cancer Research, Professor Ian Smith teaches cancer medicine. Additionally, he oversees The Royal Marsden's Breast Unit. Before beginning his career at The Royal Marsden, Professor Smith had his training at Edinburgh and Harvard. He has spent many years specializing in the medical management of breast cancer and, up until recently, lung cancer. He has pioneered the use of pre-operative medical treatment prior to surgery for big breast malignancies. His main research interests are in the discovery of innovative treatments for breast cancer, particularly in its early stages. Former Chairman of the Association of Cancer Physicians and the Lung Cancer Group of the UK National Cancer Research Institute is Professor Smith. He serves on the steering committees of numerous significant worldwide clinical research studies and most recently had a key role in the creation of Herceptin, a drug used to treat early breast cancer. Over 350 of his research publications have been published, and he frequently gives lectures abroad. View Profile

Dr. Vincent Khoo is a clinical oncology consultant and the head of the clinical oncology department at the Royal Marsden NHS Foundation Trust (RMT). He is also an honorary consultant at St. George's Hospital, which includes the Atkinson Morley Wing, an honorary senior lecturer at the Institute of Cancer Research at the University of London, and an honorary associate professor at the Austin Health School of Medicine at the University of Melbourne. He received his medical degree in 1985 and has practiced clinical oncology in the UK, the USA, and Australia. He oversees the RMT Chelsea's Urology-Oncology Unit and specializes in urological malignancies. The UK National Cancer Research Institute (NCRI) Clinical and Translational Radiotherapy Group, National Radiotherapy Implementation Group, NCRI Prostate Cancer Clinical Studies Group, NCRI Penile Cancer Clinical Studies Group, Clinical Trials Awards and Advisory Committee (CTACC) Cancer Research UK, UK Familial Prostate Cancer, Clinical Oncology Editorial Board, ESTRO and ECCO scientific subcommittee are just a few of the national and international committees he serves on. View Profile

Haematologist and oncologist Dr. Zaid Abboudi practices in London. He is currently employed by the London Cancer Centre. His credentials include FRCP, FRCPath, and DCPath. Hemato-oncology, leukemia, lymphoma, myeloma, and lymph node pathology are his areas of specialty. View Profile

At the Royal Marsden Hospital, Professor Ray Powles established and oversaw one of the largest and most cutting-edge blood cancer programs in the world until 2003. It was under his direction that the 1973 procedure that resulted in the first successful bone marrow transplant in Europe was carried out. He reported the first autologous stem cell transplant for myeloma and was the first to use cyclosporine and acyclovir. In 2003, the Queen gave him the title of Commander of the British Empire (CBE) in recognition of these and other achievements. At the Cancer Centre London, where he is the head clinician for the bone marrow transplant and haemato-oncology departments, he now oversees a comparable department in the private sector. He presided over the Scientific Committee on Plasma Cell Biology of the American Society of Haematology until December 2010. For his contributions in educating and facilitating cancer care across the continent, he received a Lifetime Achievement Award from the Indian Cancer Patients Aid Association in 1999. Professor Powles has consistently been involved in the development of pharmaceuticals, particularly with the advisory board for the pharmaceutical sector. Up until 2008, he served as a director of the Swiss biopharmaceutical business BioPartners. View Profile

Dr. John Glees is a consultant clinical oncologist who focuses on chemotherapy and radiation therapy for a wide range of malignancies. He has an MD with honors, a thesis on brain tumors, and is a Fellow of the Royal College of Radiologists in the UK (by examination). Additionally, he has a London-based Diploma in Medical Radiotherapy (DMRT). He has worked in the field of cancer treatment for 40 years. Lung, breast, skin, upper and lower GI (pancreatic, rectal, and anal), gynecological, and urological malignancies (kidney, bladder, and prostate) are among the cancers that Dr. Glees specializes in treating. Dr. Glees received his training in the US, Germany, and England. He worked with Dr. Irwin Tepper in the US to acquire his initial exposure to radiotherapy. At the University of London, he served as an Honorary Senior Lecturer from 1981 to October 2010. He is a well-known conference speaker and has a large body of publications. View Profile

Oral and maxillofacial surgeon Mr. Andrew Stewart practices in London. He is currently employed by the London Cancer Centre. His academic credentials include MB BS(Hons) BDS(Hons) FDS RCS FRCS. Impacted teeth, wisdom teeth, facial deformities, facial injuries, diseases of the salivary glands, facial skin cancer, and the diagnosis of mouth cancer are some of his areas of competence. View Profile

Prof. Robert Huddart is an expert in prostate, bladder, and testicular cancer. His areas of interest in research include the care of all testicular cancers with an emphasis on improving outcomes in high-risk diseases and minimizing toxicity in low-risk diseases, as well as the genetics of testicular cancer and its late effects. The management of bladder cancer, with a focus on the use of neoadjuvant chemotherapy and its role in the selection of patients for conservative treatment, improving conservative treatment for invasive bladder cancer through the use of concomitant therapies, and the technical advancement of radiotherapy and imaging are among other areas of interest. View Profile